As Democrats consider their post-midterm healthcare agenda, Congress is calling to investigate the role of private equity in medicine. While corporate medicine receives a lot of criticism, the alternative often leads to higher healthcare costs and less patient choice.
Before the midterm elections, Sen. Elizabeth Warren (D-MA) introduced the Stop Corporate Takeovers of Physicians Act, which would bar corporate ownership of medical practices. Even with Democrats in power come January, Warren’s bill is expected to fail — but with renewed focus, it could become model legislation for blue states, several of which are already pursuing similar models.
Such plans would bar outside investors and private equity from owning medical practices, but would exempt hospitals and nonprofit providers, allowing them to further consolidate medical practices.
I’m a patient at Liv by Advantia Health, an OB-GYN practice that sprang from a $45 million capital infusion from BlueMountain Capital Management. Appointments are easily obtained and not rushed; patient autonomy is prioritized, and referral lists are carefully curated from an extensive pool of outside specialists to address patient needs. Another exceptional telehealth company, Sword Health — which I’ve used for physical therapy — relies on corporate financing and VC to expand care access.
Warren’s bill would restrict the type of financing that built these providers even when health care consumers like me benefit from having more options. That’s not to say private equity necessarily solves every problem.
I’ve also experienced the very problems critics associate with corporate medicine. At a large venture-backed dental practice I won’t name, the dentist I saw wanted to drill out multiple cavities that later turned out not to exist. I went for second opinions from two other independent practices, and both assured me the original diagnosis was wrong.
This certainly fits the stereotype that PE providers treat patients as profit generators. But financial incentives don’t disappear when investors do. Independent physicians and hospital systems have the same incentive to profit from unnecessary procedures as well, arguably even more so if they know patients have no other options. While any provider can abuse their position, banning corporate ownership still does more harm than good.
Instead of charging a fee-for-service rate, PE can fund a variety of structures, including value-based care, which minimizes the incentive to upcharge with additional services. An October 2026 Colliers report shows that corporate money actually helps physicians to improve efficiency and expand patient access, while a 2025 research brief found no increase in closures, quality, mortality, or readmissions following PE hospital acquisitions
That’s because private equity investment can help clinics to expand by purchasing equipment, technology, and innovation to compete against large systems. Without this influx, doctors report that high administrative costs make it nearly impossible for small practices to stay afloat. Bloated hospital systems easily become buyers of bankrupt independent practices if corporate investment is heavily restricted. And as large hospital systems absorb smaller physician-owned practices, the superlarge systems can force higher prices from insurers, increasing premiums and healthcare costs without improving quality of care.
For example, the Thomas Jefferson University health system recently swallowed up physician-owned Pottstown Medical Specialists that had declared bankruptcy due to losses from drug reimbursements.
The ills in health care might be less about ownership and more about reimbursement rules.
“You cannot crush reimbursement and then ban one of the only remaining sources of capital [private equity] and call it patient protection,” says physician Clay Moss.
TRUMP’S HIPAA OVERHAUL MAKES PATIENTS THE CEOS OF THEIR HEALTH — NOT FILE CLERKS
Instead, expanding site-neutral payments so smaller, less-resourced providers can receive the same reimbursement as large hospital systems is a good first step. Payments that vary by facility create an unfair advantage for large systems with stronger bargaining power, further incentivizing consolidation and higher health care costs.
Private equity helps smaller practices stay viable, and restricting it constrains the promise of a free market in medicine. If we want to give providers more freedom to practice independently, we need to give them more options for funding, not less.
Alexandra Stinson is a Young Voices contributor.
Continue reading...
[ H/T Washington Examiner ]